Search

everythinglearnresearchcommunity

for

Search:↓

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Pioglitazone may help treat lichen planopilaris, but more research is needed.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Tridax procumbens may help treat diabetes.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Pioglitazone combined with metformin or spironolactone improves PCOS symptoms and insulin resistance.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

Upadacitinib effectively treats psoriasis and lichen planus together.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Triptorelin effectively treats central precocious puberty in Chinese children with minimal side effects.

Tofacitinib might be used to treat hair loss.

Liraglutide with metformin reduces body fat and improves blood sugar control better than metformin and inositol in women with prediabetes.

The FDA approved a new Pfizer drug for hair loss in teens.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Tazarotene gel is more effective for acne than tretinoin and works as well as adapalene.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.